Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 151 to 160 of 1686
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK MIA 3070 Insp GMP/GDP/IMP 3070/14720-0052[H] GMPC

IPSEN BIOPHARM LIMITED, ASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, LL13 9UF, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 3070 Insp GMP/GDP/IMP 3070/14720-0052[I] GMPC

IPSEN BIOPHARM LIMITED, ASH ROAD, WREXHAM INDUSTRIAL ESTATE, WREXHAM, LL13 9UF, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 25224 Insp GMP/IMP 25224/90670-0017[I] GMPC

BIRMINGHAM BLOOD CENTRE, VINCENT DRIVE, EDGBASTON, BIRMINGHAM, B15 2SG, UNITED KINGDOM

UNITED KINGDOM
UK API 10524 Insp GMP 10524/1456-0003 GMPC

THOMAS SWAN & COMPANY LIMITED, ROTARY WAY, CONSETT, DH8 7ND, UNITED KINGDOM

UNITED KINGDOM
UK GMP 22774 Insp GMP/IMP 22774/31007-0023 [V] GMPC

BIORELIANCE LIMITED, STIRLING UNIVERSITY INNOVATION PARK, HILLFOOTS ROAD, STIRLING, FK9 4NF, UNITED KINGDOM

UNITED KINGDOM
UK GMP 22774 Insp GMP/IMP 22774/31007-0023 [H] GMPC

BIORELIANCE LIMITED, STIRLING UNIVERSITY INNOVATION PARK, HILLFOOTS ROAD, STIRLING, FK9 4NF, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 101 Insp GMP/IMP 101/19062596-0012[I] GMPC

NOVARTIS PHARMACEUTICALS UK LIMITED, 2ND FLOOR, THE WEST WORKS BUILDING, WHITE CITY PLACE, 195 WOOD LANE, LONDON, W12 7FQ, UNITED KINGDOM

UNITED KINGDOM
UK GMP 57391 Insp GMP/IMP 57391/31206699-0003[H] GMPC

GFR ANALYTICAL SERVICES, UNIT A, FERN MILL, HASLINGDEN OLD ROAD, OSWALDTWISTLE, ACCRINGTON, BB5 3RG, UNITED KINGDOM

UNITED KINGDOM
UK MIA 101 Insp GMP/IMP 101/19062596-0012[H] GMPC

NOVARTIS PHARMACEUTICALS UK LIMITED, 2ND FLOOR, THE WEST WORKS BUILDING, WHITE CITY PLACE, 195 WOOD LANE, LONDON, W12 7FQ, UNITED KINGDOM

UNITED KINGDOM
UK MIA 51463 Insp GMP 51463/18851545-0005[H] GMPC

KENT PHARMA UK LIMITED, UNIT 200, WESTMINSTER 42, WESTMINSTER INDUSTRIAL ESTATE, REPTON ROAD, MEASHAM, SWADLINCOTE, DE12 7DT, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX